oral version of semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients Oral Semaglutide | Tablet Health

[34] demonstrated that LA induced apoptosis through the production of the proapoptotic TNF-alpha-related apoptosis-inducing ligand (TRAIL) cytokine in endothelial cells [34]

This is not a direct side effect of the medication itself, but rather a result of losing fat quickly

We are also collaborating closely with vendors to strategically stock up on low-dosage GLP-1 medications to minimize study delays as much as possible without impacting supply for standard of care for T2DM patients

The dose is gradually increased to minimize potential side effects

The article lists lipohypertrophy, meaning fat deposits built up from repeated injections, along with local skin infections and areas with poor sensation

Vitamin B12 monitoring is not routinely indicated for patients on GLP-1/GIP therapy alone but may be considered for those also taking metformin or with risk factors for deficiency